Example: Heart Attack

Search clinical trials for: Adrenocorticotropic Hormone

Total 206 results

NCT03727776

Recruiting

Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)

Conditions: Proliferative Vitreoretinopathy
NCT02030028

Recruiting

ACTH Gel Therapy in Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT03025828

Completed

Adrenocorticotropic Hormone in Membranous Nephropathy

Conditions: Membranous Nephropathy
NCT01906372

Completed

Acthar in Treatment of Refractory Dermatomyositis and Polymyositis

Conditions: Dermatomyositis; Polymyositis
NCT02523092

Not yet recruiting

Use of CXCL9 as a Biomarker of Acthar Efficacy

Conditions: Sarcoidosis
NCT03656692

Terminated

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

Conditions: Uveitis, Posterior; Uveitis, Intermediate; Panuveitis
NCT02245841

Recruiting

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

Conditions: Dermatomyositis; Juvenile Dermatomyositis
NCT02382523

Withdrawn

Acthar on Proteinuria in IgA Nephropathy Patients

Conditions: IgA Nephropathy; Proteinuria
NCT02633046

Completed

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

Conditions: Idiopathic Focal Segmental Glomerulosclerosis
NCT01966718

Completed

Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.

Conditions: Rheumatoid Arthritis
NCT02290444

Completed

Effects of Acthar on Recovery From Cognitive Relapses in MS

Conditions: Multiple Sclerosis
NCT02446886

Terminated

Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS

Conditions: Multiple Sclerosis
NCT03287635

Completed

Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

Conditions: Dry Eye Disease
NCT03408405

Withdrawn

ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children

Conditions: Steroid-Resistant Nephrotic Syndrome
NCT03465111

Recruiting

A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis

Conditions: Scleritis
NCT04169061

Completed

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

Conditions: Keratitis
NCT01900093

Unknown status

Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses

Conditions: Multiple Sclerosis
NCT02486744

Terminated

Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

Conditions: End Stage Renal Disease
NCT02779153

Withdrawn

Acthar SLE (Systemic Lupus Erythematosus)

Conditions: Systemic Lupus Erythematosus (SLE); Repository Corticotropin Injection
NCT02434757

Unknown status

Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT01948388

Completed

The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients

Conditions: Rheumatoid Arthritis
NCT02399462

Not yet recruiting

Acthar for Treatment of Post-transplant FSGS

Conditions: FSGS; Renal Transplantation; Kidney Transplantation
NCT02057523

Terminated

Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients

Conditions: Proteinuria; Transplant Glomerulopathy
NCT02769702

Terminated

Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

Conditions: Uveitis
NCT01129284

Completed

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Conditions: Treatment Resistant Nephrotic Syndrome